Versartis, Inc. Tech Stack

Versartis, Inc. uses 8 technology products and services including Amazon Web Services, RSS, jQuery Migrate, and more. Explore Versartis, Inc.'s tech stack below.

Amazon Web Services

Cloud Hosting

RSS

Content Management System

jQuery Migrate

Javascript Libraries

Underscore.js

Javascript Libraries

Microsoft

Miscellaneous

Acquia Cloud Platform

Platform As A Service

PHP

Programming Languages

Bootstrap

UI Frameworks

Versartis, Inc. Email Formats	Example	Percentage
FLast@versartis.com	JDoe@versartis.com	100%
FLast@aravive.com	JDoe@aravive.com	72%
First.Last@aravive.com	John.Doe@aravive.com	14%
First@aravive.com	John@aravive.com	14%

Versartis, Inc. Email Formats

Example

Percentage

FLast@versartis.com

JDoe@versartis.com

100%

FLast@aravive.com

JDoe@aravive.com

72%

First.Last@aravive.com

John.Doe@aravive.com

14%

First@aravive.com

John@aravive.com

14%

Frequently Asked Questions

Where is Versartis, Inc.'s headquarters located?

Versartis, Inc.'s main headquarters is located at 3730 Kirby Drive Suite 1200 Houston, Texas 77098 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Versartis, Inc.'s phone number?

You can contact Versartis, Inc.'s main corporate office by phone at

+1-936-355-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Versartis, Inc.'s stock symbol?

Versartis, Inc. is a publicly traded company; the company's stock symbol is ARAV.

What is Versartis, Inc.'s official website and social media links?

Versartis, Inc.'s official website is aravive.com and has social profiles on LinkedIn.

What is Versartis, Inc.'s SIC code NAICS code?

Versartis, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Versartis, Inc. have currently?

As of February 2026, Versartis, Inc. has approximately 33 employees across 2 continents, including North AmericaEurope. Key team members include Director, President And Chief Executive Officer: J. S.Owner: C. C.Vice President, Investor Relations: M. C.. Explore Versartis, Inc.'s employee directory with LeadIQ.

What industry does Versartis, Inc. belong to?

Versartis, Inc. operates in the Biotechnology Research industry.

What technology does Versartis, Inc. use?

Versartis, Inc.'s tech stack includes Amazon Web ServicesRSSjQuery MigrateUnderscore.jsMicrosoftAcquia Cloud PlatformPHPBootstrap.

What is Versartis, Inc.'s email format?

Versartis, Inc.'s email format typically follows the pattern of FLast@versartis.com. Find more Versartis, Inc. email formats with LeadIQ.

How much funding has Versartis, Inc. raised to date?

As of February 2026, Versartis, Inc. has raised $42M in funding. The last funding round occurred on Oct 25, 2022 for $42M.

When was Versartis, Inc. founded?

Versartis, Inc. was founded in 2008.

Versartis, Inc.

Q: What is Versartis, Inc.'s official website and social media links?

Versartis, Inc.'s official website is aravive.com. Versartis, Inc. has social profiles on LinkedIn.

Q: How many employees does Versartis, Inc. have currently?

Versartis, Inc. has approximately 33 employees.

Q: What technology does Versartis, Inc. use?

Versartis, Inc.'s tech stack includes TweenMax, React, Module Federation, Microsoft Azure, SiteCatalyst.

Q: What is Versartis, Inc.'s NAICS code?

Versartis, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchTexas, United States11-50 Employees

Aravive, Inc. is a late clinical-stage oncology company focused on developing targeted therapeutics to treat metastatic cancer. It is headquartered in Houston, Texas, with satellite offices in the Research Triangle Park area of North Carolina and in Bethesda, Maryland. Its technology originated in the laboratories of Dr. Amato Giaccia at Stanford University and relies on genetic screening to identify targets for cancer therapy, employing high-affinity decoy receptors to disrupt oncogenic signaling.

The company's primary focus is the GAS6-AXL pathway, a signaling axis associated with cancer cell survival and metastasis. Aravive aims for its therapies to be used as monotherapy or in combination with existing cancer treatments, and it pursues development in advanced disease settings. In August 2023, the company announced that its Phase 3 trial evaluating batiraxcept in platinum-resistant ovarian cancer did not meet its primary endpoint.

Insights

Similar companies to Versartis, Inc.

Kymera Therapeutics

xCures

TetraLogic Pharmaceuticals

Versartis, Inc. Tech Stack

Media & News

Aravive, Inc. launched Phase 3 AXLerate-OC on Aug 2nd '23.

Aravive, Inc. hired Carolina Petrini as Chief Commercial Officer on Apr 10th '23.

Prohaska leaves Aravive, Inc. as Director of Preclinical Development and Clinical Operations Support.

Aravive, Inc. received financing of $41.5M in private placement financing on Sep 30th '22.

Aravive, Inc. hired Robert B. Geller as Chief Medical Officer on Jul 5th '22.

Aravive, Inc. hired Rudy Howard as Chief Financial Officer on Jun 3rd '22.

Aravive, Inc. hired Scott Dove as Chief Operating Officer on Mar 22nd '22.

Versartis, Inc.'s Email Address Formats